Man Group PLC Dexcom Inc Transaction History

Man Group PLC

$37.2 Billion
Q1 2025

A detailed history of Man Group PLC transactions in Dexcom Inc stock. As of the latest transaction made, Man Group PLC holds 294,130 shares of DXCM stock, worth $25.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

294,130

Previous 304,415 3.38%

Holding current value

$25.6 Million

Previous $23.7 Million 15.16%

% of portfolio

0.05%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	SELL	$67.74 - $90.75 $696,705 - $933,363	-10,285 Reduced 3.38%	294,130 $20.1 Million
Q4 2024 Feb 14, 2025	SELL	$65.68 - $81.01 $46.5 Million - $57.3 Million	-707,932 Reduced 69.93%	304,415 $23.7 Million
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $15.5 Million - $28.1 Million	-241,746 Reduced 19.28%	1,012,347 $67.8 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $109 Million - $139 Million	991,319 Added 377.25%	1,254,093 $142 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $3.48 Million - $4.27 Million	30,508 Added 13.13%	262,774 $36.4 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $28.1 Million - $46.2 Million	-371,717 Reduced 61.54%	232,266 $28.8 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $7.27 Million - $11.7 Million	84,494 Added 16.26%	603,983 $56.4 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $31.8 Million - $37 Million	282,554 Added 119.25%	519,489 $66.8 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $32.2 Million - $38.1 Million	-309,641 Reduced 56.65%	236,935 $27.5 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $19.3 Million - $27.9 Million	227,338 Added 71.21%	546,576 $61.9 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $5.95 Million - $7.34 Million	77,902 Added 32.28%	319,238 $25.7 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $15.4 Million - $30 Million	225,966 Added 1470.18%	241,336 $18 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $5 Million - $6.93 Million	-53,190 Reduced 77.58%	15,370 $7.86 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $991,947 - $1.24 Million	-7,638 Reduced 10.02%	68,560 $36.8 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $3.18 Million - $4.26 Million	29,768 Added 64.11%	76,198 $41.7 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $2.48 Million - $3.31 Million	30,660 Added 194.42%	46,430 $19.8 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $918,445 - $1.13 Million	-10,832 Reduced 40.72%	15,770 $5.67 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $567,450 - $760,237	7,275 Added 37.64%	26,602 $9.84 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $696,363 - $823,518	7,291 Added 60.58%	19,327 $7.97 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $151,434 - $254,501	2,416 Added 25.11%	12,036 $4.88 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $384,948 - $609,199	8,055 Added 514.7%	9,620 $2.59 Million
Q4 2019 Feb 18, 2020	SELL	$36.62 - $57.29 $1,464 - $2,291	-40 Reduced 2.49%	1,565 $342,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $1.24 Million - $1.53 Million	-34,943 Reduced 95.61%	1,605 $239,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $680,493 - $951,321	-24,443 Reduced 40.08%	36,548 $5.48 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $1.23 Million - $1.67 Million	-43,764 Reduced 41.78%	60,991 $7.26 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $306,228 - $424,000	11,346 Added 12.15%	104,755 $12.5 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $613,381 - $964,597	26,269 Added 39.13%	93,409 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $1.18 Million - $1.69 Million	67,140 New	67,140 $6.38 Million

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account